HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Colin C Pritchard Selected Research

Drug Therapy (Chemotherapy)

12/2021Genomic attributes of homology-directed DNA repair deficiency in metastatic prostate cancer.
1/2020Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers. I. Molecular Biomarkers in Prostate Cancer.
1/2018Polyclonal BRCA2 Reversion Mutations Detected in Circulating Tumor DNA After Platinum Chemotherapy in a Patient With Metastatic Prostate Cancer.
3/2017Establishment of Patient-Derived Tumor Xenograft Models of Epithelial Ovarian Cancer for Preclinical Evaluation of Novel Therapeutics.
3/2016Somatic Mosaic Mutations in PPM1D and TP53 in the Blood of Women With Ovarian Carcinoma.
1/2016Biallelic Inactivation of BRCA2 in Platinum-sensitive Metastatic Castration-resistant Prostate Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Colin C Pritchard Research Topics

Disease

55Neoplasms (Cancer)
12/2023 - 03/2011
41Prostatic Neoplasms (Prostate Cancer)
04/2024 - 05/2015
10Microsatellite Instability
03/2020 - 12/2014
8Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 11/2010
6Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer)
07/2023 - 12/2014
5Neoplasm Metastasis (Metastasis)
01/2023 - 10/2016
5Carcinoma (Carcinomatosis)
01/2023 - 02/2014
5Lung Neoplasms (Lung Cancer)
01/2022 - 01/2013
4DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes)
01/2020 - 01/2017
2Adenocarcinoma
05/2019 - 01/2019
2Turcot syndrome
12/2018 - 12/2014
1Neuroendocrine Carcinoma
01/2023
1Genomic Instability
12/2022
1Urogenital Neoplasms
05/2021
1Xeroderma Pigmentosum (Kaposi's Disease)
01/2019
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2019
1Sepsis (Septicemia)
11/2018
1Brain Injuries (Brain Injury)
11/2018
1Brain Neoplasms (Brain Tumor)
07/2018
1Ovarian Neoplasms (Ovarian Cancer)
03/2017
1Ovarian Epithelial Carcinoma
03/2017
1Leukemia
01/2016
1Breast Neoplasms (Breast Cancer)
01/2016
1Disease Progression
01/2016
1Endometrial Neoplasms (Endometrial Cancer)
12/2014
1Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
10/2014
1Polyps
10/2014
1Sarcoma (Soft Tissue Sarcoma)
08/2014
1Leiomyosarcoma
08/2014
1Colonic Neoplasms (Colon Cancer)
07/2012
1Hemolysis
03/2012

Drug/Important Bio-Agent (IBA)

20DNA (Deoxyribonucleic Acid)IBA
12/2023 - 12/2014
17Proteins (Proteins, Gene)FDA Link
07/2023 - 10/2014
15Biomarkers (Surrogate Marker)IBA
04/2024 - 01/2011
7PlatinumIBA
12/2023 - 02/2014
6Poly(ADP-ribose) Polymerase InhibitorsIBA
12/2022 - 02/2014
6Immune Checkpoint InhibitorsIBA
01/2021 - 05/2019
5Circulating Tumor DNAIBA
12/2023 - 01/2018
5NucleotidesIBA
01/2023 - 07/2012
5Hormones (Hormone)IBA
01/2023 - 01/2020
5ErbB Receptors (EGF Receptor)IBA
01/2022 - 11/2010
5ParaffinIBA
07/2018 - 11/2010
5Formaldehyde (Formol)FDA Link
07/2018 - 11/2010
4pembrolizumabIBA
12/2021 - 01/2018
4MicroRNAs (MicroRNA)IBA
07/2014 - 03/2011
3AndrogensIBA
12/2023 - 01/2019
3Androgen Receptors (Androgen Receptor)IBA
01/2023 - 01/2019
3abirateroneIBA
01/2022 - 01/2017
3Cell-Free Nucleic AcidsIBA
06/2021 - 01/2019
3Epithelial Cell Adhesion MoleculeIBA
01/2018 - 07/2012
2AntigensIBA
01/2022 - 01/2020
2enzalutamideIBA
01/2020 - 01/2017
2Tumor Biomarkers (Tumor Markers)IBA
01/2018 - 03/2012
1177Lu-PSMA-617IBA
04/2024
1Nucleosomes (Nucleosome)IBA
01/2023
1Phenobarbital (Luminal)FDA Link
01/2023
1LigandsIBA
01/2022
1COVID-19 VaccinesIBA
01/2022
1Anaplastic Lymphoma KinaseIBA
01/2022
1RNA (Ribonucleic Acid)IBA
01/2022
1Estrogen ReceptorsIBA
01/2022
1Docetaxel (Taxotere)FDA Link
01/2022
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2022
1E 10 (E-10)IBA
12/2021
1Ataxia Telangiectasia Mutated ProteinsIBA
01/2020
1DNA-Directed DNA Polymerase (Polymerases, DNA)IBA
01/2020
1Adenosine Diphosphate (ADP)IBA
01/2020
1Messenger RNA (mRNA)IBA
01/2020
1cyclopropapyrroloindoleIBA
01/2020
1Carboplatin (JM8)FDA LinkGeneric
01/2019
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2019
1Coloring Agents (Dyes)IBA
12/2018
1Sirolimus (Rapamycin)FDA Link
11/2018
1CateninsIBA
01/2018
1Radium-223IBA
01/2018
1Programmed Cell Death 1 ReceptorIBA
01/2018
1Prostate-Specific Antigen (Semenogelase)IBA
12/2017
1EnzymesIBA
10/2016
1Checkpoint Kinase 2IBA
01/2016
1Tyrosine Kinase InhibitorsIBA
10/2015
1Phosphotransferases (Kinase)IBA
10/2015
1Amino AcidsFDA Link
02/2015
1A-Form DNA (A-DNA)IBA
12/2014
1Aurora Kinase AIBA
08/2014
1Cetuximab (Erbitux)FDA Link
01/2011
1Panitumumab (Vectibix)FDA Link
01/2011
1Monoclonal AntibodiesIBA
01/2011

Therapy/Procedure

33Therapeutics
04/2024 - 01/2011
19Castration
04/2024 - 05/2015
6Precision Medicine
01/2023 - 05/2015
6Drug Therapy (Chemotherapy)
12/2021 - 01/2016
5Immunotherapy
01/2021 - 01/2017
4Prostatectomy (Retropubic Prostatectomy)
01/2019 - 10/2016
1Radiotherapy
01/2022
1Infant Equipment (Crib)
01/2021
1Molecular Targeted Therapy
01/2018